Recombinant Human CD247 Protein，His

CD247, also known as TCRζ (T-cell receptor zeta chain), is a crucial component of the T-cell receptor (TCR) complex, playing a vital role in T-cell activation, proliferation, and function. This protein is essential for both α/β and γ/δ T-cell signaling pathways, serving as a linker that transmits activation signals from the TCR to intracellular signaling cascades. Dysregulation of CD247 has been implicated in various immune disorders, including autoimmune diseases and certain cancers, making it a significant target for therapeutic interventions. Research into the recombinant expression of CD247 aims to provide insights into its structure-function relationship and facilitate the development of T-cell-based immunotherapies. By producing recombinant CD247, scientists can study its interaction with other TCR components and signaling molecules, paving the way for novel strategies to enhance T-cell responses against tumors or regulate aberrant immune reactions. Furthermore, understanding the regulatory mechanisms governing CD247 expression and function could lead to improved vaccine design and personalized medicine approaches in immunotherapy. As a result, the study of recombinant CD247 is a promising avenue for advancing our knowledge of T-cell biology and developing innovative therapeutic strategies to combat immune-related diseases.